Target intelligence / Profile preview

Sialic acid binding immunoglobulin-like lectin 24, pseudogene (SIGLEC24P)

Target
SIGLEC24P
Molecular classification
Other (pseudogene), does *not* encode a functional protein
01

Overview

SIGLEC24P stands for “Sialic acid binding immunoglobulin-like lectin 24, pseudogene.” It is annotated as a pseudogene, meaning it is a nonfunctional segment of DNA related to the siglec (sialic acid-binding immunoglobulin-like lectin) gene family, but it does not encode a functional protein product in humans[7][9][1][5][3]. Pseudogenes often arise from duplication or retrotransposition events but have since accumulated mutations that prevent expression of a functional protein. Siglecs as a group are cell surface proteins involved in immune regulation, but pseudogene members like SIGLEC24P do not themselves participate in signaling or serve as drug targets[4][7][9]. There are no known biological functions, disease associations, interacting drugs, mechanisms of action, biomarker roles, or safety concerns specifically attributed to SIGLEC24P. The designation as a pseudogene means this entry should not be considered a therapeutic target.

Other names
SIGLECP8

Beyond the preview

Go deeper on Sialic acid binding immunoglobulin-like lectin 24, pseudogene (SIGLEC24P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sialic acid binding immunoglobulin-like lectin 24, pseudogene (SIGLEC24P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call